EchoNous

Overview
Activities
News
Next-gen Medical Devices?
Product stageSegments
Go-to-Market
?
Diagnostic devices
?

EchoNous is a MedTech company specializing in developing point-of-care ultrasound (POCUS) solutions. Its flagship product, Kosmos, is an AI-powered portable ultrasound device designed to foster patient care. Kosmos leverages deep learning algorithms to transform how clinicians assess the heart, lungs, and abdomen, enhancing capabilities for POCUS ultrasound. A key feature of the device includes Auto Preset, which seamlessly adjusts the exam preset in real time as the user scans different anatomies, ensuring optimal imaging without manual intervention. Additionally, Auto Doppler, a first-of-its-kind feature, utilizes AI technology to automatically position the Doppler sample gate at the optimal location based on the valve the user wants to interrogate, making valve interrogation more efficient. As of July 2024, these features were yet to be launched. 

The Kosmos product line includes 

1) Kosmos Plus, a fully-featured POCUS configuration that includes a medical-grade stand, transducers, AI, advanced Doppler features, and an iPad Pro priced at less than USD 21,000 

2) Kosmos Mobile, tailored for on-the-go clinicians, starts at USD 7,500 and includes an iPad Air or Pro, advanced Doppler capabilities, a choice of probes, and the Kosmos Essential Carrying Case. 

EchoNous also offers specialized probes, such as the Torso-One probe for cardiac and abdominal imaging, and the Lexsa probe for MSK, vascular, nerve, guidance, and lung imaging. 

Key customers and partnerships

EchoNous serves a diverse range of medical professionals across specialties such as anesthesiology, cardiology, critical care, emergency medicine, and family medicine. 

In July 2024, EchoNous partnered with United Medical Instruments (UMI) to expand its market presence and increase access to advanced point-of-care ultrasound technology by leveraging UMI’s network and reputation. In August 2022, EchoNous teamed up with Samsung to simplify its AI-powered hand-held ultrasound system by integrating it with Samsung’s Galaxy Tab Active Pro tablets, which helped reduce costs and streamline the system’s profile. Further in October 2024, the company partnered with Mendaera, a robotic technology company, to integrate their respective technologies.

HQ location:
Redmond WA USA
Founded year:
2015
Employees:
51-100
IPO status:
Private
Total funding:
USD 194.0 mn
Last Funding:
USD 7.0 mn (Series Unknown; Jul 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.